Awarded contract

SUPPLY OF BOTULISM ANTITOXIN HEPTEVALENT (HBAT)

Details

Value
GBP 12,955,456.35
Topic
Immunoglobulins
Published
20 June 2022

Tender description

The Chemical, Biological, Radiological and Nuclear (CBRN) team, part of Defence Equipment and Support (DE&S) organisation within the UK Ministry of Defence (MOD), has placed a contract with Emergent Biosolutions Canada Inc for the supply of Heptavalent Botulism Antitoxin (HBAT) for a period of 3 years. This is necessary to ensure maintenance of the capability with an acceptable stockholding level. Lot 1: The Chemical, Biological, Radiological and Nuclear (CBRN) team, part of Defence Equipment and Support (DE&S) organisation within the UK Ministry of Defence (MOD), intends to place a contract with Emergent for the supply of Heptavalent Botulism Antitoxin (HBAT) for a period of 10 years (5 + 5 Option Years) with an estimated value of £20M+. This is necessary to ensure maintenance of the capability with an acceptable stockholding level. Due to the estimated contract value and on the basis that it is to be placed directly with Emergent Biosolutions Canada Inc, the contract will be a Qualifying Defence Contract (QDC) and shall comply with the Single Source Contract Regulations (SSCR) 2014. It is considered that this contract can be awarded using the negotiated procedure without prior publication of a contract notice, pursuant to Public Contracts Regulations 2015; where “Regulation 32 (2)(b)(ii) allows you to use the Negotiated procedure without Prior Publication when the exclusivity is due to technical reasons”. Summary of the Technical Reason: Emergent Biosolutions Canada Inc are currently the only licensed manufacturer for HBAT (BAT®) which provides antitoxin serotypes A-G for treatment of Botulism worldwide. This product is therefore the only product which provides the full capability to Defence. Additional information: Due to the limitations of the character limit at II 2.4) Description — it is not possible to enter the full details of the single source justification, for full details of the reasoning, please email Tamika.Kelly116@mod.gov.uk so that it can be forwarded to you.

Timeline

  1. Completed: Award published20 June 2022
    Current notice
  2. Completed: Award date13 April 2023

About the buyer

Ministry of Defence is a public sector buyer in United Kingdom publishing tenders and awards on Stotles. Explore their procurement activity and find more opportunities like this one.

Relevant CPV codes

  • 33651520 · Immunoglobulins

AI insights

  • Is there a preferred supplier?
  • What are the buyers pain points?
  • What has the buyer previously procured?
  • What are the key requirements?
Sign-up to enrich

Decision makers

Connect with the people behind this procurement.

Contact nameJob titlePhone numberWork email
Head of Procurement+44 •••• ••••••
Commercial Director+44 •••• ••••••
Procurement Manager+44 •••• ••••••
Category Lead+44 •••• ••••••
Senior Buyer+44 •••• ••••••
Contracts Manager+44 •••• ••••••

Related topics

Topics related to SUPPLY OF BOTULISM ANTITOXIN HEPTEVALENT (HBAT), ranked by notice volume.

View all topics
TopicCountValue
  1. 11,699
    £1.1tn

Win more public sector contracts

Track every UK and Ireland tender in one place — set up alerts, find decision-makers, and never miss an opportunity.